CRISPR Therapeutics Investors
CRISPR Therapeutics is a prominent biotechnology company based in Cambridge, Massachusetts, United States, founded in 2013 The company specializes in developing transformative gene-based medicines using CRISPR/Cas9 technology With a focus on addressing serious diseases, CRISPR Therapeutics has attracted significant investment, totaling $56,000,000 The organization is committed to advancing its innovative therapies through rigorous research and development efforts Its strategic partnerships and collaborations further enhance its potential to revolutionize the field of genetic medicine
Investors
Industry:
FemTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2013
Employees Number:
407
Investor Type:
Angel Groups
Register and Claim Ownership